Notice2024-03384
National Heart, Lung, and Blood Institute; Notice of Closed Meetings
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
February 20, 2024
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 34 (Tuesday, February 20, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 34 (Tuesday, February 20, 2024)]
[Notices]
[Pages 12850-12851]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-03384]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Closed
Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; R13 Conference Grants.
Date: March 21, 2024.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge I, 6705
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kristin Goltry, Ph.D., Scientific Review
Officer, Office of Scientific Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health, 6705 Rockledge
Drive, Room 209-B, Bethesda, MD 20892, (301) 435-0297,
<a href="/cdn-cgi/l/email-protection#b3d4dcdfc7c1cad8dff3ded2dadf9ddddadb9dd4dcc5"><span class="__cf_email__" data-cfemail="2d4a4241595f5446416d404c444103434445034a425b">[email protected]</span></a>.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Diabetes-Sleep and Cardiovascular Risk (R01/
R34).
Date: March 21, 2024.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge I, 6705
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Zhihong Shan, Ph.D., MD, Scientific Review
Officer, Office of Scientific Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health, 6705 Rockledge
Drive, Room 205-J, Bethesda, MD 20892, (301) 827-7085,
<a href="/cdn-cgi/l/email-protection#0a7062636265646d2479626b644a646362246d657c"><span class="__cf_email__" data-cfemail="89f3e1e0e1e6e7eea7fae1e8e7c9e7e0e1a7eee6ff">[email protected]</span></a>.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; K38 Review Meeting.
Date: March 27, 2024.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge I, 6705
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kristen Page, Ph.D., Scientific Review Officer,
Office of Scientific Review/DERA, National Heart, Lung, and Blood
Institute, National Institutes of Health, 6705 Rockledge Drive, Room
209-B, Bethesda, MD 20892, (301) 827-7953, <a href="/cdn-cgi/l/email-protection#5a312833292e3f34742a3b3d3f1a343332743d352c"><span class="__cf_email__" data-cfemail="28435a415b5c4d460658494f4d68464140064f475e">[email protected]</span></a>.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; NHLBI Mentored Career Development K-Awards.
Date: March 28, 2024.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kristin Goltry, Ph.D., Scientific Review
Officer, Office of Scientific Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health, 6705 Rockledge
Drive, Room 209-B, Bethesda, MD 20892, (301) 435-0297,
<a href="/cdn-cgi/l/email-protection#65020a0911171c0e092508040c094b0b0c0d4b020a13"><span class="__cf_email__" data-cfemail="d6b1b9baa2a4afbdba96bbb7bfbaf8b8bfbef8b1b9a0">[email protected]</span></a>.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Catalyze Product Development.
Date: March 29, 2024.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
[[Page 12851]]
Contact Person: Kristin Goltry, Ph.D., Scientific Review
Officer, Office of Scientific Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health, 6705 Rockledge
Drive, Room 209-B, Bethesda, MD 20892, (301) 435-0297,
<a href="/cdn-cgi/l/email-protection#b9ded6d5cdcbc0d2d5f9d4d8d0d597d7d0d197ded6cf"><span class="__cf_email__" data-cfemail="ed8a8281999f948681ad808c8481c3838485c38a829b">[email protected]</span></a>.
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Diseases and Resources Research, National Institutes of
Health, HHS)
Dated: February 14, 2024.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-03384 Filed 2-16-24; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on February 20, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.